Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser
- PMID: 22010052
- PMCID: PMC3196304
Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser
Abstract
Objective: This study evaluated the safety and efficacy of sublative fractional bipolar radiofrequency and bipolar radio frequency combined with diode laser for the treatment of both superficial and deep acne scars in patients with skin types II to V.
Design: Prospective, single-center study. Subjects received up to five treatments with sublative fractional bipolar radiofrequency and bipolar radiofrequency combined with diode laser. Treatments were directed to at least two facial (forehead, perioral, cheeks) and/or neck areas with acne scars at four-week intervals. Treatment parameters on each subject were based on skin type and on skin responses to test spots on the target area just before treatment.
Setting: Physician office.
Participants: Subjects (n=20, aged 40.7±10.5 years [mean ± SD], skin types II-V) with acne scars and without acne lesions enrolled in this prospective study.
Measurements: RESULTS were evaluated just before each treatment and at four and 12 weeks after the final treatment using the Goodman Scar Scale, a quantitative method of evaluating scars that attempts to reduce grading subjectivity, as well as by patient satisfaction.
Results: Acne scars improved significantly one month after three treatments and improvement persisted for at least 12 weeks after the fifth treatment. Improvement was not affected by skin type. Adverse effects were limited to transient erythema and edema.
Conclusion: The combination of diode laser and bipolar radiofrequency energy device in addition to fractionated sublative radiofrequency is a safe and statistically significantly effective combined modality for the treatment of both superficial and deep acne scars in patients with skin types II to V with minimal downtime and no significant side effects.
Figures
References
-
- Jacob CE, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109–117. - PubMed
-
- Taub AF. Fractionated delivery systems for difficult to treat clinical applications: acne scarring, melasma, atrophic scarring, striae distensae, and deep rhytides. J Drugs Dermatol. 2007;6(11):1120–1128. - PubMed
-
- Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg. 2002;28(11):1017–1021. discussion 1021. - PubMed
-
- Shamban AT, Narurkar VA. Multimodal treatment of acne, acne scars and pigmentation. Dermatol Clin. 2009;27(4):459–471. vi. - PubMed
LinkOut - more resources
Full Text Sources